Nebido 1000 mg / 4 ml Solution for injection
PDF Leaflet Revision Date: 02 August 2022
Clinical Summary
Quick overview from the medicine insert
Indication
Testosterone replacement in male hypogonadism.
Dosage (summary)
1000 mg every 10 to 14 weeks; may start at 6 weeks for loading dose.
Onset of Action / Duration
Onset: 1 day, Duration: 10-14 weeks
Special Populations
- Elderly
- Hepatic impairment
- Renal impairment
Pregnancy & Breastfeeding
Not applicable; may reduce spermatogenesis.
Key Drug Interactions
- Increased activity of oral anticoagulants
- Enhanced effects of hypoglycemics
Contraindications
- Androgen-dependent carcinoma
- Liver tumors
- Hypersensitivity
- Women
Common side effects
- Acne
- Injection site pain
- Polycythaemia
- Hypertension
Counselling Points
- Inject intramuscularly only
- Monitor testosterone levels
- Report any severe abdominal pain
Serious warnings
- Risk of prostatic hyperplasia
- Thrombotic events
- Potential for abuse
Important Disclaimer
The Nebido 1000 mg / 4 ml Solution for injection professional information leaflet below is the property of Bayer and is provided on Medinsert exactly as issued, with no.. alterations or editorial changes. We make every effort to keep content current by updating documents as soon as new versions become available. Medinsert serves as a trusted access point for healthcare professionals, but does not replace official sources or clinical judgement. For more details, please read our full disclaimer. read more>>
Healthcare Professionals Only
This content is for registered healthcare professionals
Sign in or create a free account to read the full package insert.
Free for HPCSA-registered professionals. Powered by Medinsert.
